Related Experiment Video

Updated: Nov 20, 2025

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

692

Advances in Pathogenesis of Idiopathic Membranous Nephropathy

Zhifeng Xu1, Lu Chen2, Huiling Xiang1

  • 1Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Kidney Diseases (Basel, Switzerland)
|January 25, 2021
PubMed
Abstract

Insights

Idiopathic membranous nephropathy (IMN) is increasingly prevalent. Discoveries in molecular and genetic pathogenesis, including PLA2R and THSD7A, are revolutionizing IMN diagnosis and treatment, aligning with precision medicine.

Area of Science:

  • Nephrology
  • Immunology
  • Genetics

Background:

  • Membranous nephropathy (MN) is a significant cause of nephrotic syndrome with rising prevalence.
  • It is a leading cause of end-stage renal disease (ESRD) and a common cause of glomerulopathy recurrence post-kidney transplantation.

Purpose of the Study:

  • To review recent advancements in understanding the pathogenesis of idiopathic membranous nephropathy (IMN).
  • To discuss the diagnostic and therapeutic implications of novel molecular and genetic discoveries in IMN.

Main Methods:

  • Literature review focusing on molecular and genetic aspects of IMN pathogenesis.
  • Analysis of recent findings on M-type phospholipase A2 receptor (PLA2R) and thrombospondin type-1 domain-containing 7A (THSD7A).
  • Examination of genetic studies, including single nucleotide polymorphisms in PLA2R1 and HLA genes.

Main Results:

  • Identification of PLA2R and THSD7A as key targets in IMN.
  • Elucidation of genetic factors, such as PLA2R1 and HLA gene polymorphisms, contributing to IMN pathogenesis.
  • Demonstration of how these discoveries offer new diagnostic and treatment strategies.

Conclusions:

  • Advances in molecular and genetic research have significantly improved the understanding of IMN.
  • New diagnostic methods and targeted therapies are emerging based on molecular discoveries like PLA2R and THSD7A.
  • Genetic insights into IMN align with the principles of precision medicine, paving the way for personalized treatment approaches.
Keywords:
Membranous nephropathyPhospholipase A2 receptorPodocyte autoantigenSingle nucleotide polymorphismsThrombospondin type-1 domain-containing 7A

More Related Videos

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin07:38

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin

Published on: May 6, 2018

8.6K
Isolation of Glomeruli and In Vivo Labeling of Glomerular Cell Surface Proteins09:12

Isolation of Glomeruli and In Vivo Labeling of Glomerular Cell Surface Proteins

Published on: January 18, 2019

9.7K

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
269
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
73
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
548
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
550
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
289
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
355